Glenmark Pharmaceuticals’ subsidiary — Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (USFDA) for Bisoprolol Fumarate and Hydrochlorothiazide Tablets USP, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, the generic version of Ziac Tablets, 2.5 mg/6.25 mg, 5 mg/6.25 mg, and 10 mg/6.25 mg, … Read more
Glenmark Pharmaceuticals is currently trading at Rs. 533.95, up by 10.30 points or 1.97% from its previous closing of Rs. 523.65 on the BSE. The scrip opened at Rs. 523.00 and has touched a high and low of Rs. 539.50 and Rs. 523.00 respectively. So far 77079 shares were traded on the counter. The BSE … Read more
Glenmark Pharmaceuticals has reported results for second quarter ended September 30, 2018. The company has reported over 2-fold jump in its net profit of Rs 747.56 crore for the quarter under review as compared to Rs 327.88 crore for the same quarter in the previous year. Total income of the company increased by 28.48% at … Read more
